Intérêt de l’utilisation du logiciel TB-info® pour le suivi des patients mis sous traitement antituberculeux : analyse des 208 patients de la cohorte 2004

Abstract: Introduction: The impact of the TB-info® software was assessed on the care of patients treated with antituberculosis regimen (ATT). Methods: Cohort study of patients with tuberculosis who received an ATT in 2004 in two hospitals and five medical centres in Paris. Follow-up was implemented with the TB-Info® software. Data were compared to those of the 1999–2003 cohort. Results: Two hundred and nine ATT were initiated in 2004, with a mean duration of 7.2 months. Demographic and clinical data reflected this population precariousness: 79% were foreign-born, 25% lived in institutions and half of them had no or unusual health insurance. Compared to the previous cohort, viral co-infections were tested in more than 80% cases and showed association with HIV, HBV or HCV in 11, 10 and 5% of the patients, respectively. Twenty-one patients were lost for follow-up (11%) and 76% of the smear-positive pulmonary tuberculosis therapies were declared successful but only 34% were declared cured with the WHO criteria. Conclusion: Analysis of the data obtained with TB-info® software showed an improvement of tuberculosis patients care with more co-infection tested and less lost for follow-up. These results confirm the usefulness of this software for patients care and assessment of physicians practice in France. [Copyright &y& Elsevier]